Showing results (211-220 of 412) with videos related to

Sort By:
Pageof 42
The Journal of Antimicrobial Chemotherapy|April 25, 2024
Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infectionWeeraya Phaisal, Orwa Albitar, Pajaree Chariyavilaskul, et al.
Lung|July 11, 2020
Pulmonary Arteriovenous Malformations in Non-hereditary Hemorrhagic Telangiectasia Patients: An 18-Year Retrospective StudyHasan Ahmad Hasan Albitar, Justin M Segraves, Yahya Almodallal, et al.
Cancer|May 13, 2004
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemiaYupo Ma, Adnan Mansour, B Nebiyou Bekele, et al.
American Journal of Clinical Pathology|June 11, 1999
Comparison of touch imprints with aspirate smears for evaluating bone marrow specimensR Aboul-Nasr, E H Estey, H M Kantarjian, et al.
American Journal of Clinical Pathology|June 30, 2000
Immunohistochemistry can be used to subtype acute myeloid leukemia in routinely processed bone marrow biopsy specimens. Comparison with flow cytometryE J Manaloor, R S Neiman, D K Heilman, et al.
The New England Journal of Medicine|March 8, 2002
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cellsMartin Körbling, Ruth L Katz, Abha Khanna, et al.
World Journal of Methodology|September 29, 2023
Role of endoscopic ultrasound and endoscopic ultrasound-guided tissue acquisition in diagnosing hepatic focal lesionsHussein Hassan Okasha, Hanane Delsa, Abdelmoneim Alsawaf, et al.
Blood|July 11, 2000
Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemiaA Aguayo, S O'Brien, M Keating, et al.
European Journal of Haematology|September 3, 2003
Molecular differences between small and large cells in patients with chronic lymphocytic leukemiaJeong N Lee, Fancis Giles, Yang O Huh, et al.
Scandinavian Journal of Urology|July 2, 2020
A prospective study of a urine and plasma biomarker test for the prediction of gleason ≥3 + 4 prostate cancer in a mixed cohortMads Hvid Poulsen, Søren Feddersen, Maher Albitar, et al.
Pageof 42